Delivery Order SPE2DB20D9127-SPE2DB24FPRB0
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. The contract, valued at $151,711.62, has a completion date of January 3, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of XTANDI 40 mg capsules. The contract, valued at $25,868.10, has an ultimate completion date of May 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This single-award indefinite delivery contract (IDC), valued at up to $499,999,999, was issued under the SPE2DB program to meet the recurring pharmaceutical needs of military health facilities worldwide. DMS Pharmaceutical Group specializes in providing a wide range of branded and generic...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the prescription medication XTANDI 40 MG. This order, valued at $4,311.35, will be fulfilled by December 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. The Firm Fixed Price contract is valued at $4,311.35 and has an ultimate completion date of May 23, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain division, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, valued at $4,311.35. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S and has a completion date of February 28, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to government agencies, particularly the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the supply of a pharmaceuticals item, XTANDI 40 MG CAPSULE 120S, with a performance period through September 9, 2024. DMS Pharmaceutical Group is an established federal contractor that holds a large $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the prescription medication XTANDI 40 MG. The order, valued at $4,311.35, was awarded on January 23, 2024 with a completion date of January 24, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and delivery orders with DLA to supply a variety of pharmaceutical and medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...